In May 2024, he joined Shanghai Lishan Biomedicine Co., LTD
Master of Hospital Administration and Doctor of Public Health, University of Alabama Birmingham, USA, licensed physician in the United States, and certified clinical pathology specialist in the United States. Dr. Li Changqing has extensive experience in phase I-IV global clinical trials in the fields of oncology, immunotherapy, anti-inflammatory, gastrointestinal and gynecological diseases. He has led hundreds of clinical trials and more than 30 new drug filings worldwide.